CLABSI Prevention With Tissue Adhesive
Recruiting
N/A
Interventional Study
Central-line Associated Blood Stream Infections (CLABSI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 0 Days – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 600 (estimated)
- Sponsor
- Rabin Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):
* young age\<1y \& Congenital Heart Surgery Mortality Category (STAT\\STS-EACTS) score 2-5
* Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
* preoperative length-o…
Contacts